Money Trade Plan - A Blog To Share A High Profit Trading Signals In Forex, Stocks, Futures, Option Trading, ICO, BLOCKCHAIN And Bitcoin.Building the Perfect Master Plan

Thursday, July 27, 2017

TRADE PLAN OF THE DAY ($DOX) AND ALIBABA OPTION TRADE CLOSED FOR PROFIT OF 20%

Hi Guys,

We are once again seeing record highs for the major indices at midday, and it is the ongoing strength in earnings news that is powering the lift. Facebook (FB) followed the upside earnings trend yesterday after the bell and the stock is up more than 5% in midday trading. Having traditional industrial companies and the FANG stocks releasing great earnings is a huge plus for this bull market, but it just makes some bulls wonder how long this party can last. The Fed sounded dovish on rates yesterday, but who knows?


In economic news, weekly jobless claims came in at 244,000 versus last week's 234,000 and the expected 245,000. This indicates that the employment picture is holding up extremely well. June durable goods orders rose 6.5% versus the expected 5.3% increase and May's 0.1% decline. We will see if we can build on these midday gains, so stay tuned! On a side note, Amazon's (AMZN) Jeff Bezos has officially surpassed Microsoft's (MSFT) Bill Gates as the world's richest man. Bezos is now just above $90 billion, while Gates' is slightly below $90 billion. This is definitely a "wow" moment for Bezos, who began 20 years ago selling books online at a loss!

Amdocs Ltd. (DOX)

July 28, 2017


COMPANY DESCRIPTION

Amdocs Limited (DOX) is a global provider of software and services solutions to the communications, entertainment, and media industry service providers.




INVESTMENT THESIS

Amdocs is currently trading at less than 17 times our 2017 earnings estimate, a very reasonable multiple for a growing telecommunications company. At current levels, we believe there is significant upside to the shares. The shares have consistently posted gains in recent years and are less volatile than many other technology companies and downside risk is limited in our opinion.

Amdocs business has been consistent. Revenue has risen 2%-3% or more every year since 2012, while operating margins have increased 10-20 basis points over that same time period. The company’s customers include the largest communications and content service providers, providing Amdocs with a predictable revenue stream.

DOX has a long history of returning cash to shareholders by way of share buybacks and dividends. Management has increased the dividend 14% annually since a dividend was initiated in 2012. The dividend is currently $0.22 per share, which yields 1.4%. On average, Amdocs has spent more than $400,000 annually on share buybacks, reducing the share count from 187 million to 151 million in five years.



RECENT DEVELOPMENTS

On May 9, the company reported a strong second quarter with revenue and earnings above our estimates. We are encouraged that the company’s business with AT&T (T) is recovering from weakness seen in the first half of 2016. Amdocs reported second-quarter revenue of $966 million, $5 million above the consensus estimate. Operating earnings rose from $0.86 in 1Q16 to $0.94 per share, matching the consensus estimate. Higher earnings reflect a second straight quarter of recovery in the North American market, which grew 8.5%. Amdocs continued to benefit from the pay TV market in the U.S. during the second quarter. The gross margin expanded 20 basis points to 35.5%, while operating margin rose from 16.6% to 17.2%.



EARNINGS GROWTH & ANALYSIS

We expect the company’s dominant market position to result in consistent 2%-5% revenue growth. We expect the industry to continue to grow at a low-single-digit pace and expect DOX to benefit from that growth.

For 2017, we now estimate earnings of $4.00 per share, up from a prior $3.90. For 2018, we are raising our estimate from $4.20 to $4.25 per share.



RISKS

Amdocs receives more than a third of total revenue from AT&T and just 10 just customers contribute more than 70% of the company’s business. In 2016, AT&T decided to postpone a project and this significantly influenced Amdocs’ growth. Europe is about one-eight of revenue and consists of many projects, which are sometimes delayed. Amdocs has pointed out that its business is won through competitive bidding, so if it is less effective in winning bids its business could decline.



VALUATION

We rate Amdocs a BUY and are establishing a target price of $80. Our price target implies a multiple of 20 times our estimate, which is above historical multiple. However, multiples for the Software Technology sector have widened in recent years and we believe a premium is warranted. At its current price, the shares offer investors the prospect of a 20% total return.



Amdocs Ltd. (DOX)
Current Price: $67.39
Target Price: $80
Current Valuation: 16.8 times FY17 EPS
Target Valuation: 20 times FY17 EPS



Alibaba Group Holding Ltd. (BABA), Achieved Its $159.30 Price Target

The following weekly Option Trades option idea should have been closed today for a 20% profit, as the underlying stock in the recommendation, Alibaba Group Holding Ltd. (BABA), achieved its $159.30 price target. The reason that the return was not nearly as high as the 99.36% anticipated return is because BABA achieved its target in just THREE DAYS, and most of the time premium was left in the options.


Ideas presented on 7/24/17

Call (Bull) Debit Spread on Alibaba Group Holding Ltd. (BABA, current price $152.26)
Buy 10 - October 2017, $150 strike calls for $10.75
AND
Sell 10 - October 2017, $160 strike calls for $6.10

Based upon Trades' projected share price of $159.30 at (or before) expiration on 10/20/17, Return on Investment (ROI) would be 99.36% (including reasonable commission) if BABA rises 4.62% in the next 12 1/2 weeks. Options are suitable for only very aggressive investors.
CLOSED ON 7/27/17 for approximately a 20% profit

Previous ideas can be seen here: HERE


WE ACCEPT TIP INCENTIVES
AND WE APPRECIATE IT.
Send your TIPS to my bitcoin address below...THANK YOU!

Bitcoin Address: 16uoUH9cTC5Mpf7QttdRkKHdV2XBc5b3XS

Happy investing! ☺





 Our Credo: What's Good for YOU!..Good For Us and vice versa!...

 Disclaimers

 Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Share:

Monday, July 24, 2017

Best Trade of the Week: Alibaba Group Holding Ltd. ($BABA) And Sunrun Inc. ($RUN)

Trade of the Week Sunrun Inc. (RUN)  

Hello Guys,
In the interest in staying with what has been working, Trade ideas technology is giving us a few contenders that look to push to new 52 week highs with the help of short sellers capitulating and creating yet another short squeeze in this market environment.  Sunrun Inc. (RUN) has caught our eye as such a candidate from the “Squeeze Me” scan.
The suggested entry price of buying RUN is conditional of the stock trading above 7.35 this week. RUN has earnings in 11 trading days and also a short float of 28%; meaning 28% of the stock holders might start buying their shares back if RUN trades too far above 7.35. This could potentially propel RUN higher over a few days of “short squeezing” the short sellers.
The suggested stop for RUN will be a trade back below 6.85. The suggested near term target on the daily chart will be 8.40 which is a resistance level going back to May of 2016. The risk is 50 cents and the reward is 1 dollar on this Trade of the Week idea. As always size your position to allow for 50 cents of risk should this trade not work. Managing risk is always our number one priority.
Footnote:   This is a table showing the maximum profit for all past 2017 Trades of the Week. Timing the top is impossible but this table shows how much alpha was possible when considering the exit of these positions. The trades outlined in red eventually hit their suggested stop prices, so you can see the importance of timing and harvesting profits along the way when you can, especially those that move above 10%. 
*Assumptions
Targets are not absolute. Targets involve timing. Profits can and should be harvested along the way.
Risk to Reward ratio ideal is 1:3
Trades of the week that do not reach entry prices are not considered live and are expired at the end of the current week. (ORCL and JNPR)
TOW Rules: 20% Rule.  If a performance is up 10% and gives back 20%, take the 8 and run. (Profit Save, Trailing Stop).
Stocks that gap up over the entry price are considered up to the discretion of the buyer as to the entry price (WETF)
FOR OPTION TRADING OF THE WEEK!
Option Trade of the Week- The best option idea each week, based on projected potential return, with less than a $5000 investment and no margin requirement.

Call (Bull) Debit Spread on Alibaba Group Holding Ltd. (BABA), current price $152.26)
Buy 10 - October 2017, $150 strike calls for $10.75
AND
Sell 10 - October 2017, $160 strike calls for $6.10

Based upon Trades' projected share price of $159.30 at (or before) expiration on 10/20/17, Return on Investment (ROI) would be 99.36% (including reasonable commission) if BABA rises 4.62% in the next 12 1/2 weeks. Options are suitable for only very aggressive investors.


WE ACCEPT TIP INCENTIVES
AND WE APPRECIATE IT.
Send your TIPS to my bitcoin address below...THANK YOU!

Bitcoin Address: 16uoUH9cTC5Mpf7QttdRkKHdV2XBc5b3XS
Happy investing! 



Our Credo: What's Good for YOU!..Good For Us and vice versa!...

Disclaimers

Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Share:

Thursday, July 20, 2017

Top 3 Option Trading Signals With The Big News From A Healthcare Company & What It Means For Your Portfolio -Inogen Inc. (INGN)


Market Outlook: The euro rally will probably continue and reach beyond the recent high at 1.1583, but first it has to pull back when Draghi disappoints. The only question is how far. The channel bottom lies at 1.1462 and we don’t expect to see a level much lower than that. But the previous intermediate low was 1,1369 and a test of that level is always a possibility. 


Reuters reports that dollar shorts reduced positions ahead of the ECB and Draghi, which is the better way to look at it. On the 15-minute chart, the euro stopped falling when the ECB statement of no change was released. But that doesn’t mean the slide will not resume, depending on what Draghi says. Draghi is sensitive to the effect on the euro of his comments. We can probably assume he knows perfectly well that if he admits the council talked about tapering, the euro will rally. At the same time, Draghi would never, ever lie about it. We like the comment in the FT from a fund manager: “The euro is on track to reach $1.25 by the end of the year, but it won’t be a straight line and today could be a good reason to take some profits on recent moves against the dollar,” says Paul Brain, head of fixed income at Newton Investment Management. “For currencies the interest rate story is most important, as changing interest rate differentials drive currencies. If the ECB’s tone switches from reducing stimulus spending to discount rate increases then the euro could accelerate. But that’s probably for the ECB and Fed September meetings.” 

Stocks got off to a positive start today with the Nasdaq and S&P 500  touching all-time highs, but we have seen a bit of a pullback that has put the major indices slightly lower at midday. Earnings season is in full force, and the numbers we have seen have generally been solid.strong housing starts and building permits numbers provided some good news for economy watchers who were concerned that we were seeing too many pockets of weakness, so the hope among bulls is that this trend continues in the weeks ahead.

We did get some additional "good news" regarding the economy today in the form of the index of Leading Economic Indicators (LEI) for June, which came in at 0.6% versus May's 0.2%. The reason this is great news for the economy is that the LEI is a forward-looking indicator, unlike most economic reports that say what happened one or two months in the past. Bulls were pleased to see the LEI jump as much as it did, so this could provide some "upside fuel" for the stock market as we head toward August and the rest of the summer.

Stay tuned!

       

HIGH PROFIT TRADING SIGNALS



SELL GBP/USD- recommended entry @ 12981( DAY TRADING)) STOP- 13026, TAKE PROFIT- 12933
BUY EURO/USD- recommended entry @ 11576 ( DAY TRADING)) STOP- 11542, TAKE PROFIT- 11616
BUY AUD/USD -recommended entry @ 7942 ( DAY TRADING)) STOP- 7913, TAKE PROFIT- 7972
BUY USD/JPY- recommended entry @ 11226 ( DAY TRADING)) STOP- 11192, TAKE PROFIT- 11265
SELL USD/CHF- recommended entry @ 9560 ( DAY TRADING)) STOP- 9585, TAKE PROFIT- 9531
SELL USD/CAD- recommended entry @ 12597 ( DAY TRADING)) STOP- 12630, TAKE PROFIT- 12560

CME/Globex FX FUTURES--SEP 2017 Contract 
BUY AUD @ 7950, STOP- 7915, TAKE PROFIT- 7992
BUY MEX PESO @ 5611, STOP- 5568, TAKE PROFIT- 5655
SELL GBP @ 13016, STOP- 13070, TAKE PROFIT- 12953




Stocks Trading Idea For Today ($INGN)



Inogen Inc. (INGN)

July 21, 2017

COMPANY DESCRIPTION

Inogen Inc. (INGN) develops, manufactures and markets portable oxygen concentrators (POC). Patients who suffer from chronic respiratory conditions and require long-term oxygen therapy use POCs. POCs purify the air around the patients and remove nitrogen and other unnecessary substances and provide oxygen.


INVESTMENT THESIS

Long-term Oxygen Therapy increases survival and improves the quality of life for patients suffering from hypoxemia (insufficient oxygen in the blood) with chronic obstructive pulmonary disease. The Total Addressable Market (TAM) for these patients in the U.S. is between $3 billion to $4 billion. INGN estimates that there are 2.5-3.0 million patients in the U.S. and more than 4.5 million patients worldwide who use oxygen therapy. The U.S. market for oxygen therapy is expected to grow between 7% and 10% from 2017 to 2021. We think U.S. and international markets will provide Inogen significant growth.

POCs solve many of the problems associated with conventional oxygen therapy that use stationary oxygen concentrators systems for use in the home and oxygen tanks or cylinders for mobile use. POCs provide unlimited oxygen anywhere, improving patient independence and mobility. POCs are less expensive than traditional therapies as these treatments do not require infrastructure and require less maintenance. We believe the benefits and lower cost of POCs will enable Inogen to gain share much faster than the competition.

The company’s direct-to-customer business has helped it become a leader in the oxygen therapy market. INGN efforts to market its direct-to-customer sales have led to enhanced brand recognition. An increase in physician referrals is also expected to boost revenue over the next several years.

We expect underpenetrated international markets and positive reimbursement trends in France, Germany, and the U.K. to provide significant international growth. In particular, Germany is believed to be the second largest market in Europe for medical oxygen systems. Increasing demand in the Asia Pacific region also bodes well for INGN.


RECENT DEVELOPMENTS

On May 9, Inogen posted first-quarter earnings of $0.27 per share, well above the year ago and consensus figure of $0.12. The positive earnings surprise reflected 22% higher revenue of $53 million, well above the consensus estimate just below $50 million.

Product sales rose 40% to $46 million, while rental revenue dropped 36% to $7 million. Business to business(B2B) sales in the U.S. soared 84% to more than $17 million, primarily reflecting purchases by traditional home medical equipment providers and ongoing strength in private label sales. Internationally, business-to-business sales grew 15% to more than $11.

Direct-to-consumer product sales in the U.S. rose 28% to nearly $17 million. However, direct-to-consumer rental revenue decreased 36% to $6.5 million.
In the first quarter, INGN reported a gross margin of 49%, down from 49.5% in the prior year period. Sales gross margins increased from 49.7% to 52.3%. The improvement reflected lower cost of goods sold, according to management. Rental gross margin fell from 49% in 1Q16 to 26% in 1Q17. The decline reflected lower net revenue per patient. Adjusted EBITDA rose 34% to $11 million year over year. 

Earnings & Growth Analysis

Inogen maintained its 2017 adjusted EBITDA guidance. However, INGN increased its 2017 adjusted net-income forecast. It projects revenue in the range of $233-$239 million, above the previous forecast of $230-$236 million. This represent annual growth of 15%-18%. Inogen expects rental revenue to decrease in 2017 due to lower average rental revenue per patient.

Adjusted EBITDA is expected to be between $46 million and $50 million, an increase of 15% year over year. INGN expects adjusted net income to be between $22 million and $24 million, up from a prior $21-23 million. For 2017, to reflect the first-quarter earnings beat, we are setting our adjusted earnings estimate at $1.20. In 2018, we see earnings growing to $1.40 per share.


RISKS

The shares typically trade at multiples above 70 and disappointing results or other bad news could cause the stock to plummet. A significant portion of Inogen’s revenue comes from Medicare reimbursements, which could be cut. The company also derives a significant portion of its revenue from international markets and foreign exchange is likely to be a headwind.


VALUATION

Our $115 target price is based on a multiple of 95.8 times our 2017 earnings estimate. We believe that Inogen’s rapid growth and prospects for positive earnings surprises warrant a lofty valuation. At its current price, our target price, if achieved offers investors the prospect of a 20% return.
Inogen Inc. (INGN)
Current Price: $96.18
Target Price: $115
Current Valuation: 80.1 times FY17 EPS
Target Valuation: 95.8 times FY17 EPS



OPTION TRADING TRADING SIGNALS


Naked Puts on Wynn Resorts (WYNN)


12 Trades That Can TRIPLE in 12 Months
It has been a lousy few years for casino stocks with a presence in Macau. Wynn Resorts, Limited (NASDAQ:WYNN) has really been in trouble over there, along with everyone else, as the Chinese government continues its crackdown on corrupt rich people.
The Chinese chose to do this because, with 2 billion people to mollify, it cannot appear as coddling the corrupt and the rich. Thus, with fewer rich people eager to flash their cash, the casinos got gobsmacked. WYNN stock is really a trading stock to me, and not a long-term investment. Still, with the stock well off its all time highs at $133.17, there is plenty of upside (and limited downside) if you buy in here.
The premiums are fantastic right now, and I might think about selling the 25 Aug $133 naked puts for $6, if you can get it. That’s a generous return of 4.5%, or 45% annualized.
There is downside to WYNN, and sure, it could crater back down to $60. However, I think the worst of the crackdown is over. WYNN doesn’t always say when it reports earnings, but it is usually the first week of the second month of the quarter.

Naked Puts on Priceline (PCLN)


PCLN stock is trading at $1,875, after backing out net cash, or 22 times next year’s earnings. Its earnings per share are growing at a rate of 17.6% annualized, so I consider this to be a reasonably priced growth stock. So getting PCLN stock put to you at a lower price would be wonderful.Priceline Group Inc 
(NASDAQ:PCLN) has historically been a stock where I aim to make very large premiums. You can make several thousand dollars provided you have the margin available to sell a naked put against PCLN stock.
You can sell the weekly 25 Aug $1,800 naked puts for $10.50, and collect $1,050 in premiums for income. It sounds too good to be true, but you pick up a thousand bucks, and if the stock is put to you, you get it at a nominal price of $1,790. Backing out net cash, you get it at $1,665, which is about 19.5 times FY18 earnings. PCLN reports earnings on Aug. 8.


Naked Puts on Southwest Airlines (LUV)


As an airline stock, it also means that LUV stock has the right degree of volatility to sell naked puts against it to make some additional income. If LUV stock is put to you, you get a premier airline at a discounted price from its close of $61.41 on Wednesday.Southwest Airlines Co 
(NYSE:LUV) remains one of the top two airlines, as far as financial health is concerned. LUV has always been the best-managed airline with the best financials, best cash flow and least amount of debt.
Earnings will be reported next week, on July 27. With the stock at $61.41 now, the play here is probably the 25 Aug $61 naked puts for $1.80. This works out to a higher-than-average return of about 3%. For the 36-day holding period, that bring you to a 30% annualized return.
LUV stock is also barely 5% off its all-time high. It remains a strong stock and may even be worth buying at these prices.


WE ACCEPT TIP INCENTIVES
AND WE APPRECIATE IT.
Send your TIPS to my bitcoin address below...THANK YOU!
Bitcoin Address: 16uoUH9cTC5Mpf7QttdRkKHdV2XBc5b3XS


HAPPY INVESTING!


Our Credo: What's Good for YOU!..Good For Us and vice versa!...

Disclaimers

Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Share:

HIGH PROFIT TRADING SIGNAL FOR TODAY

The dollar index is improving, if feebly, after a big two-day drop. A small improvement in the 10-year yield may deserve the credit, a rise to 2.274% from 2.263% at the close yesterday. Meanwhile, the Bund yield continues to flop downward ahead of the ECB policy meeting, results tomorrow.

In other markets, oil is up and at the highest in about two weeks, although not likely to surpass the $50 mark, despite yesterday’s API estimate of crude inventories at a build of 1.628 million barrels (when a 3 million draw was forecast). Gasoline inventories did drop. We get the Energy Dept version this morning and it could contradict the API. Also, oilprice.com reports Saudi Arabia is rumored to be considering a 1 million bpd cut to speed up the global inventory draw down.

Separately and weirdly, just as the US starts trade talks with China featuring a ban on dumped steel, iron ore prices in China are rallying like crazy. Either they need the iron/steel themselves or they feel sure they can sell the stuff elsewhere. Reuters reports steel beats oil in Asian commodity markets “because of cuts in low-grade steel production capacity that have reduced supply as demand has remained surprisingly strong…. Since the start of the year, prices for Chinese steel rebar, used mainly in construction, have surged by almost a third this year to more than 3,800 yuan ($562.42) per tonne.” Iron ore itself has jumped 17% since July 1 on demand for housing and infrastructure.

The euro is starting to recover from the usual post-rally pullback that took it from yesterday’s high at 1.1583 to a low overnight at 1.1513 just after Asian passed the baton to Europe. The 2-hour chart here shows red support at around 1.1514 this morning, the linear regression at around 1.1511 and the midpoint of the breakout bar (green) at 1.1503. Without any fancy theories, we can deduce true support near 1.1505-1.1510.



The Reuters 10-year yield index closed at 2.264% from 2.309% but is quoted a little firmer at 2.274% this morning.

The Bund yield is quoted at 0.551% from 0.563% yesterday and 0.582% last Friday morning.

Market Outlook: Fresh data today in the US consists only of housing starts, not normally a change agent but possibly important this time. In May, starts disappointed on the downside, only 1.092 million when 1.215 was forecast. The 5.5% drop in May followed -2.7% in April and -7.7% in March. A fourth month of decline could be a loud whistle that something is amiss when the economy is supposedly enjoying full employment. May permits fell 4.9% to 1.17 million, suggesting June starts could be awful.

Institutional factors always beat economic data. The key institutional factor is always the central bank. We get both the BoJ and ECB today and tomorrow. The BoJ policy meeting tomorrow will see some members retiring and new ones coming in. Little change is expected, although analysts keep expecting a change in the inflation target rate to make the actuals look less bad.

The more-watched central bank is the ECB, which has to walk a tightrope between admitting lower inflation and inflation expectations and robust conditions that warrant tapering. Some tapering, any tapering. We all know it’s going to be a long drawn-out affair but traders are getting impatient to see it acknowledged and started. We continue to guess that Draghi will repeat inflation is not sustainable and everyone will be disappointed again. Reuters reports some insiders want to keep the buying program open-ended. Well, gee. Of course any central bank worth its salt is going to say that purchases can be ramped back up if conditions warrant. Bloomberg reports the ECB staff is working on a “stimulus plan,” which seems to be a misuse of language when what they are really designing is a measured retreat from QE with a reduced pace of asset purchases.

And everyone still expects Draghi to offer some hints and clues at the Kansas City Fed’s shindig in Jackson Hole on August 24-26. We always expect more from Jackson Hole than we end up getting.

In the US, of new institutional importance since Trump is the ability of the US government to get anything done. We had “Infrastructure Week” but no infrastructure plans. We are having “Made in America Week” this week but absolutely nothing on how the US is supposed to replace imports. It’s showmanship and PR rather than governance.

Congress is now considering yet another unviable approach—repeal Obamacare but delay the actual date for two years to give Congress time to devise another plan. The Plubs blame the Dems for their own failure (the pot calling the kettle black) but no informed person sees anything except disarray and incompetence. Usually it’s the Dems who are an incoherent mess so this is kind of fun.

But the problem remains that the Trump administration has achieved nothing in its first six months except a little immigration policy change. Doubts are growing by leaps and bounds that tax reform is going to go the same way as the healthcare bill. For one thing, it’s being designed in secret by a small group of only six persons. If ever you need transparency, disclosure, expert testimony and hard data from statisticians and economists, it’s on tax reform. The suspicion is not unfounded that the reform designers will seek what Plubs always seek—lower taxes for the rich.

Then there’s trade. Most people have their eyes glaze over when the word comes up. But the Trumpies are counting on the public and even the commentariat to wish trade would just go away. But trade is not all that complicated and it formed a solid leg on which the Trump electoral victory rested. We are stuck with it.

Today the US and China meet for something named a “Comprehensive Dialogue,” meaning stuff other than trade will be allowed. The US wants China to stop dumping cheap steel into the US (a product Trump himself buys for his buildings) and also to step up its work in reining in N. Korea. A few facts—the US now imports hardly any steel from China, and China has already said (more or less) it can’t do anything with N. Korea. The US trade deficit with China is $347 billion, the biggest two country deficit of all time.

The FT reports “The problem is that the United States already blocks most Chinese steel imports. So any tariffs or limits on imports would instead hurt other countries, including such staunch allies as Canada and South Korea.” One analyst suggests “the United States could try to coordinate sanctions against China by countries that do import Chinese steel.”

But wait, there’s a bomb coming. Commerce Sec Ross will be releasing a paper on the role of steel in national security. Think airplanes and tanks. If the president chooses, he can use a 1962 law that allows him to ban imports or set a catastrophic tariff on goods deemed central to national security. This would play well in those places where voted chose Trump. Therefore we expect it.

At the same time, China has a trump card, the purchase of US Treasuries. The latest TICS report shows China increased its holdings for the 5th month in a row to $1.10 trillion. (Japan has a little more, $1.11 trillion). The FT reports China’s holdings rose by $10 billion in the May month and is the highest since last Oct. China has yet to threaten to stop buying US paper but it’s one hell of an ace.

In other international relations, the US is falling far short of the threats it made on NAFTA, so far, and the peso and CAD remain firm. But just wait. If and when Trump needs a shocker to distract attention from his son taking a meeting with a Russian agent or the next scandal, NAFTA will come back up. Separately, the Trump administration says it may take strong action against Venezuela if the country re -writes the constitution, including sanctions against Us imports of oil. As we showed yesterday, the US imports the most from Saudi Arabia and Canada, but Venezuela is the third biggest oil exporter to the US. Trump, projecting again, said Maduro is “a bad leader who dreams of becoming a dictator.”

The pinkos and “deep state” aficionados will love it.

Finally, trade permeates other matters, too, especially Brexit. Moody’s warns that the probability is high the UK cannot make a trade deal with the EC and such a failure would trigger a recession. Some players are not waiting for things to fall apart. Citigroup picked Frankfurt as the post-Brexit location for European sales and trading. It will also move activities to Dublin, alongside Bank of America. Think tank Bruegel says 10,000 banking jobs could go in London, along with some €1.8 trillion of assets. “Standard Chartered, as well as Japan's Nomura and Daiwa Securities, have already picked the German city as their EU headquarters, while Goldman Sachs, JP Morgan, Morgan Stanley and Deutsche Bank have all said they would increase staffing in Frankfurt.” Yikes



Stock Market Update

Helped by some of the mega-cap, FANG tech stocks, the Nasdaq is touching more all-time highs and is up more than 0.5% at midday. The rest of the majors are also higher at midday, and we even received some help from some strong housing data. Housing starts for June came in at a 1.215 million rate, which topped estimates of 1.163 and May's 1.122 million, so having housing still looking solid adds to the renewed optimism we are seeing in the broader stock market.

As for the political picture, the mess in Washington DC continues. The strange thing is that despite the division and the failure of the health care vote, the stock market has moved to new highs. It used to sound very cynical and unpatriotic to say "division in government was great for the stock market." But here we are, seeing parties divided internally as well as big divisions between both national parties. And yet despite these issues, stocks are somehow rallying. So stay tuned, as bulls hope we can build on today's early gains!






HIGH PROFIT TRADING SIGNALS



SHORT USD/JPY - SIGNAL STRENGTH "STRONG"  @ ANY PRICE OR BETTER POSITION TRADE (LONG TERM OR ATLEAST 100 PIPS OR ABOVE TO TAKE PROFIT AND 70 FOR STOP LOSS)
SHORT USD/BRL- SIGNAL STRENGTH "WEAK" @ ANY PRICE OR BETTER POSITION TRADE (LONG TERM OR ATLEAST 100 PIPS OR ABOVE TO TAKE PROFIT AND 70 FOR STOP LOSS)


Stocks Trading Idea For Today ($RCL)



Royal Caribbean Cruises Ltd. (RCL): ABOVE $112.60, with a $121 first target, a $135 second target, and a $103.50 stop loss. Confirmation Volume Area= 1M, Risk Rating= 3, Industry= Resorts & Casinos
RCL TRADING TIP: Watch this choppy formation as it sets up for another stage higher, while the market posts gains. When reviewing new trading ideas for purchase, consider buying in pieces by following strength (DCA UP). NOTE: the use of the “Confirmation Day” concept drastically reduces trade risk.

Royal Caribbean Cruises Ltd. (LRC) rose $0.71, to $112.56 on good volume today! RCL operates as a cruise company. RCL operates cruises under the Royal Caribbean International, Celebrity Cruises, and Azamara Club Cruises brand names. The Royal Caribbean International brand provides a range of itineraries ranging from 2 to 24 nights with options for onboard dining, entertainment, and other onboard activities to various destinations. The Celebrity Cruises brand offers itineraries ranging from 2 to 18 nights to various destinations; and operates onboard upscale ships that offer accommodations, fine dining, personalized services, and spa facilities. The Azamara Club Cruises brand offers cruise itineraries ranging from 3 to 21 nights that serve the up-market segment of the North American, the United Kingdom, and Australian markets. RCL also operates ships under the partner brands, such as TUI Cruises, Pullmantur, and SkySea Cruises. RCL operates 49 ships with itineraries ranging from 2 to 24 nights on approximately 535 destinations worldwide.


Trades Option Idea: Transaction Closed For +50% Profit

The following weekly Trades option idea should have been closed today for a 50% profit, as the underlying stock in the recommendation, Raytheon (RTN), achieved its $169.24 price target. The reason that the return was not as high as the 99.35% anticipated return is because RTN achieved its target a month prior to expiration, and much of the time premium was left in the options.

Ideas presented on 5/30/17
Call (Bull) Debit Spread on Raytheon (RTN)

Buy 10 - August 2017, $160 strike calls for $6.40
AND
Sell 10- August 2017, $170 strike calls for $1.78

Based upon MonetradeplanTrades' projected share price of $169.24 at (or before) expiration on 8/18/17, Return on Investment (ROI) would be 99.35% (including reasonable commission) if RTN rises 3.93% in the next 11 1/2 weeks. Options are suitable for only very aggressive investors.
CLOSED ON 7/19/17 for approximately a 50% profit

Previous ideas can be seen here: HERE






WE ACCEPT TIP INCENTIVES
AND WE APPRECIATE IT.
send your TIPS to my bitcoin address below...THANK YOU!
Bitcoin Address: 16uoUH9cTC5Mpf7QttdRkKHdV2XBc5b3XS


Our Credo: What's Good for YOU!..Good For Us and vice versa!...

Disclaimers

Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Share:

Tuesday, July 18, 2017

STOCK TRADING SIGNALS AND MARKET INSIGHTS FOR TODAY - The Current Signal For Masimo Corporation Is BUY

The dollar index fell Friday on bad inflation and retail sales data, and fell again last evening around 8 pm when the news emerged that an additional two senators would not support the U.S health care bill, depriving the leader of enough votes and killing it again.

This was always the likely outcome but the timing was a surprise. The WSJ has a story on the Commitment of Traders report for the dollar index showing it had already fallen to a 3-year low (see the chart in the Market Outlook below). We can’t recall the last time a failed piece of US legislation moved the FX market like this—it’s a rare occurrence and probably reveals that traders were just itching for an excuse.

The narrative has it that the health care bill is a prerequisite for the budget and tax reform plan. The Trump initiatives that are supposed to deliver 4% growth are therefore stalled, hence the dollar effect. Analysts are throwing in reduced odds of the September rate hike, too, providing a double whammy,

In Australia, the RBA minutes were interpreted as hawkish, pushing the AUD up over 0.7900 for the first time since May 2015, helped along by the falling dollar. Evidence that the driver was the US healthcare bill comes from New Zealand, where the NZD fell on inflation falling short of forecasts (1.7% in Q2 after 2.2% in Q1 and vs. 1.9% expected). But the NZD turned around smartly on the US news. The NZD first fell from 0.7331 to 0.7261 on the domestic story, but reversed to 0.7362 in a sharp V on the US news. See the mini-chart. It’s really quite remarkable.


In the UK, June CPI was flat and the year-over-year rate decelerated to 2.6% from 2.9%. Regular core inflation also slowed to 2.4% from 2.6^ and the new CPIH (H refers to housing) version fell to 2.6% from 2.7%. We haven’t seen a fall in inflation since last fall, which accounts for the previously growing sense that the BoE could or should be raising rates. We never bought it but the expectation was a factor holding up a currency that should be falling because of Brexit. Sterling was rising against the dollar along with all the other currencies (to a high of 1.3126 overnight), but crashed on release of the inflation data to 1.3008 by 7:30 am ET. Again, a rare sharp reversal.


Yesterday the euro surpassed the previous high of 1.1490 from last week, but by only one point. At around 8 pm last evening, two senators announced they would not vote for the health care bill and the euro soared to 1.1532 in the next hour alone and thence to 1.1564 by 7 am.



The Main Event The Reuters 10-year yield index closed at 2.309% and is quoted at 2.301% from the Friday close as 2.319%. It’s now back under the 200-day moving average.

The Bund yield is quoted at 0.563% from 0.574% yesterday and 0.582% Friday morning.

Market Outlook: The dollar was showing some signs of a small rebound after the Friday rout in the usual Tuesday pullback, but the death of the health care bill put the kybosh on that. Restoring the dollar downtrend was not a gentle process—it was sharp and fast. The speed and ferocity are going to go a long way to converting diehard holdouts who want to think that the Fed will act in Sept and the outright yield differential continues to favor the dollar.

On Thursday the pro-dollar crowd is probably going to get a small dose of favorable news when Draghi holds the press conference. We guess Draghi will not change a syllable of his judgment last time—that inflation is not on a sustainably rising path. The taper gang will be disappointed. But then they can turn to the Draghi speech at Jackson Hole in August. Golly, maybe he will give some clues then. This is FX trading on wishful thinking. But to be fair to traders, recent eurozone data does point to conditions that permit tapering to be entertained, if not executed just yet.

The euro-favorable aspects of tapering are well-known by now. The dollar-negative aspects of Trump’s incompetence are only just starting to be admitted. The WSJ story on the falling dollar index notes that bearish sentiment is already the most in three years. Bears are the strongest since June 2014. See the chart. “The failure suggested Mr. Trump’s other legislative efforts, such as overhauling the tax code and implementing fiscal stimulus, might also encounter obstacles.”

We don’t necessarily agree about the legislative agenda—see “Politics” below—but the fact remains that the Trump Phenomenon overall was always going to be dollar-disastrous. Picking fights with allies and neighbors over trade, insulting Mexicans, pulling out of the Paris Climate Accord, making kissy-kissy with the Saudis and Russians, nepotism, misogyny—take your pick. And that’s not even considering

North Korea. Commentators were blunt and brutal about LePen and quick to attribute the euro’s occasional softness to political risk. Now the US and the dollar are the ones with high and rising political risk.


The next specific Trump act will be to distract and deflect attention from the heathcare failure. Alas, it’s probably another assault on NAFTA. Yesterday at the launch of “Made in America Week” (despite nearly all of Trump products being manufactured outside America), Trump said reducing US trade deficits with Canada and Mexico are the top priority in renegotiating NAFTA. He sent a list of bullet-point priorities to Congress—outsourcing again. The target is the deficit with Canada (($11 B) and Mexico (($64.3 B in 2016). Oh, yes, Trump includes a ban on those countries “manipulating their currencies to gain competitive advantage.”

Plenty of Congressmen already oppose tinkering with NAFTA out of self-interest, including both Dems and Plubs. We won’t see large crowds of public protests, but changing NAFTA is not going to go well for Trump.

Bottom line, as the latest Reuters poll shows, the rising dollar has hit the wall. “While Reuters foreign exchange polls this year have predicted the dollar to strengthen slightly, the latest poll of around 70 strategists taken over the past week showed the outlook has broadly dimmed. “A majority of strategists, 43 of 71, who answered an extra question said their dollar outlook was less bullish now compared with the beginning of the year. Seventeen said they were more bearish, only five said they were more bullish, and the remaining six strategists said they were less bearish.” Morgan Stanley admits the euro is already at its year-end forecast of 1.1500. JP Morgan says "There is further scope for recent EUR trends to extend, but this is contingent on how ongoing ECB rhetoric unfolds from here." Well, no kidding.

Politics: Trump did not take the actions that a normal president takes to get his agenda rolling and get it passed by Congress. By outsourcing the health care bill to political leaders and then failing to visit key voter districts and rally the public for the bill, Trump let down the party. The party let down its constituents by declining to hold public hearings and gather evidence and testimony from experts. The whole process was mismanaged from start to finish. What turned the four senators was public protests against the bill, despite hardly anyone knowing what was in it and in the absence of the usual CBO analysis showing costs and benefits.

The public now believes health care is a right, whatever ideologues think. In a way, the death of the health care bill is the death of the Tea Party, which wanted to slash the size and reach of the federal government, something a lot more people would have supported if the Tea Party had not also embraced religion-contaminated social values. We sometimes despair of the US voter as willfully ignorant and unbelievably stupid, but then it pulls a rabbit out of the hat and kills a very bad bill.

A great many Congressmen and voters wanted to repeal Obamacare as a fatal punch in the face to Obama personally. Obama achieved a lot more than a healthcare bill—including killing Osama bin Laden—but the Affordable Healthcare act became a symbol of his entire presidency. Nobody knows how much racism plays a part in the repeal initiative. It’s funny and sad that when pollsters ask whether voters like Obamacare, the majority say no. But when asked if they want to keep their current healthcare without naming Obama, the majority say yes. Now that’s a toxic political environment and it was invented entirely out of whole cloth by Republican Congressional representatives. But after the House voted more than 50 times to repeal the act and now the ultimate failure in the Senate reveals a terrible disconnect between the people and the legislators.

Such a disconnect is not all that abnormal or rare. We elect these guys to do a job but don’t want to have to watch them do it—until they screw up. We do not buy the thesis that all the rest of the Trump agenda, if you can call it that, is going to get the same degree of interest among the voters. Analysts bemoan that this failure shows the whole Trump plan is at risk. No, it doesn’t. For one thing, there is no plan. Trump makes it up as he goes along. Congress is the one that will have to devise a plan. For another, health care is a special case. You don’t see hundreds of thousands of protesters when Congress passes bills favoring tax breaks for rich people. We won’t see them out protesting in force when we get to the infrastructure bill, either—unless there are a lot of eminent domain issues.

Bottom line, the Trump Reflation Trade in not beheaded. It was always wishful thinking in the first place rather than a true plan, and you simply cannot kill wishes. Like Arnold, he will be baaaack.




HIGH PROFIT TRADING SIGNALS



BUY GBP/USD- recommended entry @ 13045 ( DAY TRADING)) STOP- 12996, TAKE PROFIT- 13106
BUY EURO/USD- recommended entry @ 11508 ( DAY TRADING)) STOP- 11476, TAKE PROFIT- 11548
SELL AUD/USD -recommended entry @ 7870 ( DAY TRADING)) STOP- 7841, TAKE PROFIT- 7909
SELL USD/JPY- recommended entry @ 11251 ( DAY TRADING)) STOP- 11291, TAKE PROFIT- 11203
SELL USD/CHF- recommended entry @ 9597 ( DAY TRADING)) STOP- 9626, TAKE PROFIT- 9565
SELL USD/CAD- recommended entry @ 12620 ( DAY TRADING)) STOP- 12654, TAKE PROFIT- 12580

CME/Globex FX FUTURES--SEP 2017 Contract 
BUY AUD @ 7862, STOP- 7834, TAKE PROFIT- 7892
BUY MEX PESO @ 5653, STOP- 5626, TAKE PROFIT- 5687
BUY GBP @ 13075, STOP- 13022, TAKE PROFIT- 13142




Stocks Trading Idea For Today ($MASI)



Disclaimer: We're not suggesting buying this featured company specifically - only suggesting it for further investor research. 

MASI$95.1400-0.4600% -0.4800Masimo Corporation
Sector : MedicalIndustry : Medical Instruments

  • Signal
  • Short Term Trend
  • Long Term Trend
  • BUY
  • UP
  • UP
Day:-0.48%Wk:1.98%Mo:2.21%Yrly:80.77%YTD:41.16%
Strength Rank:93DIV%:0.00PE:46.23EPS:0.57ROE:24.19%
Ann EPS Gro:2.04%Last QTR EPS Gro:11.76%Sales Gro QTR:1.69%
Beta:0.8Mkt Cap:4BVolume:0.63MBook Value:11.28Ex:NASDAQ

Long Term Trend

The long term trend of Masimo Corporation is UP indicating that MASI has experienced an UPtrend for at least the past 180 trading days. Long term trends are key to understanding the starting point to the path of least resistance of a stocks price trend. The expected future trend bias is always strongest with the current trend.

Short Term Trend

The short term trend of Masimo Corporation is UPMASI has been undergoing a short term UPUP over the past 7-10 days.

Signal

The current signal for Masimo Corporation is BUY indicating that the stock could be Advancingin its trend. The current price trend is Extreme. Stocks in extreme levels of price trend should be allowed to move out of the extreme range before a buy or sell decision should be made. As is the case for most trending momentum style stocks, much of the reason
price action is not often known until well into the price trend. But earnings growth and management efficiency are key components to a foundation to a sustainable uptrend. We will focus on fundamental indications that can build a case for reasons why the stock should continue its current trend.

Strength Rank

Rank is the rank of the stock vs. its peers. For example a Rank of 98 means the stock is out performing 98% of its peers over a 12 month period. A rank of 2 means the stock is outperforming 2% of its peers, in other words, 98% of its peers are out performing it. 98 is good, 2 is not so good. The current quarter is 40% of the weighting, so current performance is more significant to the rank.

The current rank for Masimo Corporation is 93, this means that MASI is out performing 93%of its peers. Stocks that have a rank of 80 or better, with support of all other analyses shown here, tend to advance the trend.

The 90 day trend of Rank

ROE - Return on equity is a measure of financial efficiency, gauging how much profit a company is able to generate from the company&#39s financial net worth (that is, assets minus liabilities). Look for an annual return on equity of at least 20%. That is the level that set apart the winning stocks from the ordinary. That doesn't always mean that a company with smaller ROE is a poor investment. Some big winners have of course been shy of 20% return on equity when they started their major up trends. When ROE is strong, it gives investors an indication that the company is better poised to continue a solid earnings performance. A high ROE is only part of the fundamentals a solid company should have. Superb earnings and sales growth, superior profit margins and big operating cash flow are other key elements investors must seek.

The Current ROE for Masimo Corporation is 24.19%, indicating MASI is currently functioning with High financial efficiency.

The 12 month chart trend of ROE

Annual EPS Growth - Companies with annual earnings growth of more than 20% are more likely to become leaders in up trending markets. While 20% Annual EPS growth is the minimum you should look for, don't be afraid to seek even better results. Studies have shown that the greatest winners in the past 30 years had an average 30% annual EPS growth rate when they started their strong up trends. You also can look for three straight years of rising EPS growth, with an average of at least 25%. These performance results often imply that a company is growing fast even if the general economy is slowing down or even in recession.

The current Annual EPS Growth for Masimo Corporation is 2.04% which is less than the 30% average found is strong trending, fundamentally sound companies.

The 12 month chart trend of Annual EPS Growth

Quarterly EPS Growth - Outstanding earnings growth in the most recent quarters can be the single most important trait that identifies winners before they start their major price advances. Generally, the bigger the earnings growth, the better. Specifically, look for a company's earnings per share up at least 25-30% vs. the year-ago level in the most recent quarter or two. Gains of 50%, 100% or more are typical of strong market leaders even before they make their huge price moves. There's really nothing magic about this connection. Successful companies generate the strongest profit gains, regardless of the economic cycle. Even during periods when corporate profits are weak in general, you still find standouts that achieve massive earnings growth.

The current Quarterly EPS Growth for Masimo Corporation is 11.76% which is less than the 25% average found is strong trending stocks even during or before huge price moves.

The 12 month chart trend of Quarterly EPS Growth

Quarterly Sales growth - A company's annual and quarterly rate of increase in revenues (sales). A measure of growth and success as long as it is accompanied by an equally strong rate of increase in earnings per share. You want to see both in a potential investment. A company's quarterly EPS gain should be supported by an increase in revenue (sales) of at least 25% or at least by an acceleration in sales growth in the past few quarters. You also should watch out for earnings growth that comes amid falling sales. Companies with declining revenue often boost their EPS results through layoffs or other cost cuts, especially in an uncertain economic environment. But this isn't a sustainable approach, and it's definitely not as desirable as profit gains that come from higher revenue. Recent quarterly sales results are more critical when it comes to researching stocks.

The current Quarterly Sales Growth for Masimo Corporation is 1.69% which is less than the 25% average found is strong trending stocks.

The 12 month chart trend of Quarterly Sales Growth

Dividend Yield

Dividend yield is the annual dividend income per share received from a company divided by its current share price. Normally investors would like to see a dividend yield between 2% and 20% for a dividend paying company. The dividend yield is an important factor to consider when investing in dividend paying stocks. Dividend yield is a financial ratio that reflects the % of profits a company makes of the dividend payments over the course of a year. For example if a stock pays an annual dividend of $2 and is trading at $50 a share, it would have a dividend yield of 4%.

The current Dividend Yield for Masimo Corporation is 0.00.


Stocks Historical Trading Characteristics.

           Trade Stats for   MASI

Number of Trades3Trade Expectancy$2146.64
Total Profit Amount$7264.58Trade Expectancy%21.47%
Total Loss Amount$0.00Annual Trade Expectancy$6439.93
Net Profit/Loss$7264.58Annual Trade Expectancy%64.4%
Avg Profit on Winners$2421.53Largest Profit$5436.98
Avg Loss on Losers$0.00Largest Loss$0.00
Total Net % Gain or Loss72.65%Avg Days in Trade131
Avg % Gain on Winners21.47%Avg Days between Trades26
Avg % Loss on Losers0.00%Longest nbr of consecutive Winners3
Reward to Risk Ratio0.00Longest nbr of consecutive Losers0
Number of Trades Per Year3Largest Drawdown0.00
Number of Winners3Avg Drawdown0.00
Number of Losers0
Winning Percentage%100.00%



Backtesting a stock can provide investors with critical statistical data. These results give you an informed perspective on how a stock trades within your chosen buying and selling method of analysis. The definition of trade expectancy is defined as: trade expectancy = (probability of win * average win) - (probability of loss * average loss). If the calculation returns a positive number, a trader should make money over time.

The average percentage gained on positive, money making trades was 21.47%. While the average percent loss on money losing trades was 0.00%.

Trade expectancy includes both winners and losers. Trade expectancy is displayed as a percentage. This backtest displays the dollar value, percentage, annual trade expectancy, and annual percent. Annual expectancy is the trade expectancy percentage multiplied by the number of trades per year.

The Trade expectancy % for MASI over the past year is 21.47%. The number of trades generated per year was 3 giving an Annual Trade Expectancy of 64.4%

The average days in a trade is 131 and the average days between trades is 26.

With any method of analysis that uses past performance, it can be said that past performance is not indication of future performance. What is does provide is a probabilistic look at a stock's price activity characteristics over time.



The historical Profit and loss curve of a $10,000 shows

Stocks Trading Idea For Today ($HELE)



Helen of Troy Ltd. (HELE): ABOVE $95.85, with a $104 first target, a $120 second target, and an $87 stop loss. Confirmation Volume Area= 150K, Risk Rating= 5, Industry= Housewares & Accessories
HELE TRADING TIP: Watch this VOLATILE formation as it sets up for another stage higher, while the market finishes mixed. Any further accumulation may break this stock higher, helping it take a run into ‘uncharted territory’. When reviewing new trading ideas for purchase, pay the price that coincides with your desired exit strategy; being patient by waiting for desired prices may drastically reduce trade risk. NOTE: when building a portfolio of Trade Picks, consider diversifying by “risk rating”; the action may drastically reduce trade risk.

Helen of Troy Ltd. (HELE) rose $1.05, to $95.40 on good volume today! HELE develops, imports, markets, and distributes a portfolio of consumer products worldwide. HELE operates in four segments: Housewares, Health & Home, Nutritional Supplements, and Beauty. The Housewares segment offers food and beverage preparation tools and gadgets, storage containers, and organization products; household cleaning products, and shower organization and bathroom accessories; feeding and drinking products, child seating products, cleaning tools, and nursery accessories; and insulated water bottles, jugs, drinkware, travel mugs, and food containers. The Health & Home segment provides thermometers, blood pressure monitors, and humidifiers; faucet mount water filtration systems and pitcher based water filtration systems; and air purifiers, heaters, fans, and dehumidifiers. The Nutritional Supplements segment offers heart, digestive, joint, blood sugar, sleep, brain, and vision support products; and skin care, safe beauty, and pain relief support products. The Beauty segment provides hair, facial, and skin care appliances, as well as grooming brushes, tools, and decorative hair accessories; and liquid hair styling, treatment and conditioning products, shampoos, skin care products, fragrances, deodorants, and antiperspirants. HELE sells its products through mass merchandisers, drugstore chains, warehouse clubs, home improvement stores, catalogs, grocery and specialty stores, beauty supply and e-commerce retailers, wholesalers, and various types of distributors, as well as directly to consumers under the OXO, OXO Tot, Hydro Flask, Vicks, Braun, Honeywell, PUR, Febreze, Revlon, Pro Beauty Tools, Sure, Pert, Infusium23, Brut, Ammens, Hot Tools, Bed Head, Dr. Sinatra, Dr. David Williams, and Dr. Whitaker brands.




WE ACCEPT TIP INCENTIVES
AND WE APPRECIATE IT.
send your TIPS to my bitcoin address below...THANK YOU!
Bitcoin Address: 16uoUH9cTC5Mpf7QttdRkKHdV2XBc5b3XS


HAPPY INVESTING!



Our Credo: What's Good for YOU!..Good For Us and vice versa!...

 Disclaimers

 Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Share:
Powered by Myfxbook.com

Market Quotes are powered by Investing.com

SELECT YOUR LANGUAGE

BEST TECHNICAL ANALYSIS GURU

TELEGRAM JOIN NOW : professional trader and trainer ... forex,stocks,commodity, cryptocurrency,futures,options,etc contact me :

Google+ Followers

Powered by Blogger.

Blog Archive

Follow by Email

Video Of Day

Links

Theme Support